Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide

HELSINKI, Jan. 26, 2024. Nanoform Finland Plc ( " Nanoform " ), the medicine performance-enhancing company, today announced that one of its leading nanoformulation drug products had received promising clinical results. These were from a relative...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials